List of Tables
Table 1. Global Anti-inflammatory Biologics Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-inflammatory Biologics Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-inflammatory Biologics Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Anti-inflammatory Biologics Manufacturers Covered in This Study
Table 5. Global Anti-inflammatory Biologics Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Anti-inflammatory Biologics Sales Share by Manufacturers (2015-2020)
Table 7. Global Anti-inflammatory Biologics Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Anti-inflammatory Biologics Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Anti-inflammatory Biologics Sales Sites and Area Served
Table 11. Manufacturers Anti-inflammatory Biologics Product Types
Table 12. Global Anti-inflammatory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Anti-inflammatory Biologics Players
Table 16. Global Anti-inflammatory Biologics Sales (K MT) by Region (2015-2020)
Table 17. Global Anti-inflammatory Biologics Sales Market Share by Region (2015-2020)
Table 18. Global Anti-inflammatory Biologics Revenue (Million US$) by Region (2015-2020)
Table 19. Global Anti-inflammatory Biologics Revenue Market Share by Region (2015-2020)
Table 20. North America Anti-inflammatory Biologics Sales by Country (2015-2020) (K MT)
Table 21. North America Anti-inflammatory Biologics Sales Market Share by Country (2015-2020)
Table 22. North America Anti-inflammatory Biologics Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Anti-inflammatory Biologics Revenue Market Share by Country (2015-2020)
Table 24. Europe Anti-inflammatory Biologics Sales by Country (2015-2020) (K MT)
Table 25. Europe Anti-inflammatory Biologics Sales Market Share by Country (2015-2020)
Table 26. Europe Anti-inflammatory Biologics Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Anti-inflammatory Biologics Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Anti-inflammatory Biologics Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Anti-inflammatory Biologics Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region (2015-2020)
Table 32. Latin America Anti-inflammatory Biologics Sales by Country (2015-2020) (K MT)
Table 33. Latin America Anti-inflammatory Biologics Sales Market Share by Country (2015-2020)
Table 34. Latin America Anti-inflammatory Biologics Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Anti-inflammatory Biologics Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Anti-inflammatory Biologics Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Anti-inflammatory Biologics Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country (2015-2020)
Table 40. Global Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 41. Global Anti-inflammatory Biologics Sales Share by Type (2015-2020)
Table 42. Global Anti-inflammatory Biologics Revenue (Million US$) by Type (2015-2020)
Table 43. Global Anti-inflammatory Biologics Revenue Share by Type (2015-2020)
Table 44. Global Anti-inflammatory Biologics Price (USD/MT) by Type (2015-2020)
Table 45. Global Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 46. Global Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 47. Global Anti-inflammatory Biologics Sales Growth Rate by Application (2015-2020)
Table 48. AbbVie Anti-inflammatory Biologics Corporation Information
Table 49. AbbVie Description and Business Overview
Table 50. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. AbbVie Main Product
Table 52. AbbVie Recent Development
Table 53. Johnson & Johnson Anti-inflammatory Biologics Corporation Information
Table 54. Johnson & Johnson Corporation Information
Table 55. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Johnson & Johnson Main Product
Table 57. Johnson & Johnson Recent Development
Table 58. Amgen Inc Anti-inflammatory Biologics Corporation Information
Table 59. Amgen Inc Corporation Information
Table 60. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Amgen Inc Main Product
Table 62. Amgen Inc Recent Development
Table 63. AstraZeneca PLC Anti-inflammatory Biologics Corporation Information
Table 64. AstraZeneca PLC Corporation Information
Table 65. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. AstraZeneca PLC Main Product
Table 67. AstraZeneca PLC Recent Development
Table 68. Pfizer, Inc Anti-inflammatory Biologics Corporation Information
Table 69. Pfizer, Inc Corporation Information
Table 70. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Pfizer, Inc Main Product
Table 72. Pfizer, Inc Recent Development
Table 73. Novartis Anti-inflammatory Biologics Corporation Information
Table 74. Novartis Corporation Information
Table 75. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Novartis Main Product
Table 77. Novartis Recent Development
Table 78. Roche Anti-inflammatory Biologics Corporation Information
Table 79. Roche Corporation Information
Table 80. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Roche Main Product
Table 82. Roche Recent Development
Table 83. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Corporation Information
Table 84. Sun Pharmaceutical Industries Ltd Corporation Information
Table 85. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Sun Pharmaceutical Industries Ltd Main Product
Table 87. Sun Pharmaceutical Industries Ltd Recent Development
Table 88. Sanofi Anti-inflammatory Biologics Corporation Information
Table 89. Sanofi Corporation Information
Table 90. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Sanofi Main Product
Table 92. Sanofi Recent Development
Table 93. GlaxoSmithKline Anti-inflammatory Biologics Corporation Information
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. GlaxoSmithKline Main Product
Table 97. GlaxoSmithKline Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Anti-inflammatory Biologics Distributors List
Table 101. Anti-inflammatory Biologics Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Anti-inflammatory Biologics Sales (K MT) Forecast by Type (2021-2026)
Table 106. Global Anti-inflammatory Biologics Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Anti-inflammatory Biologics Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Anti-inflammatory Biologics Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Anti-inflammatory Biologics Sales (K MT) Forecast by Application (2021-2026)
Table 110. Global Anti-inflammatory Biologics Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Anti-inflammatory Biologics Sales (K MT) Forecast by Region (2021-2026)
Table 112. Global Anti-inflammatory Biologics Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Anti-inflammatory Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Anti-inflammatory Biologics
Figure 2. Global Anti-inflammatory Biologics Sales Market Share by Type: 2020 VS 2026
Figure 3. Synthetic Type Product Picture
Figure 4. Biological Type Product Picture
Figure 5. Global Anti-inflammatory Biologics Consumption Market Share by Application: 2020 VS 2026
Figure 6. Arthritis
Figure 7. Respiratory Diseases
Figure 8. Dermatology
Figure 9. Gastroenterology
Figure 10. Others
Figure 11. Global Anti-inflammatory Biologics Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-inflammatory Biologics Sales Capacity (K MT) (2015-2026)
Figure 13. Global Anti-inflammatory Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Anti-inflammatory Biologics Sales Share by Manufacturers in 2020
Figure 15. Global Anti-inflammatory Biologics Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Anti-inflammatory Biologics Revenue in 2019
Figure 17. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Anti-inflammatory Biologics Sales Market Share by Region (2015-2020)
Figure 19. Global Anti-inflammatory Biologics Sales Market Share by Region in 2019
Figure 20. Global Anti-inflammatory Biologics Revenue Market Share by Region (2015-2020)
Figure 21. Global Anti-inflammatory Biologics Revenue Market Share by Region in 2019
Figure 22. North America Anti-inflammatory Biologics Sales Market Share by Country in 2019
Figure 23. North America Anti-inflammatory Biologics Revenue Market Share by Country in 2019
Figure 24. U.S. Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 25. U.S. Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 27. Canada Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Anti-inflammatory Biologics Sales Market Share by Country in 2019
Figure 29. Europe Anti-inflammatory Biologics Revenue Market Share by Country in 2019
Figure 30. Germany Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 31. Germany Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.K. Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 37. Italy Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 39. Russia Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Region in 2019
Figure 41. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Region in 2019
Figure 42. China Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 43. China Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 45. Japan Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 47. South Korea Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 49. India Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 51. Australia Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 53. Taiwan Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 55. Indonesia Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 57. Thailand Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 59. Malaysia Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 61. Philippines Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 63. Vietnam Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Anti-inflammatory Biologics Sales Market Share by Country in 2019
Figure 65. Latin America Anti-inflammatory Biologics Revenue Market Share by Country in 2019
Figure 66. Mexico Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 67. Mexico Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 69. Brazil Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Country in 2019
Figure 74. Turkey Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 75. Turkey Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 77. Saudi Arabia Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 79. U.A.E Anti-inflammatory Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Anti-inflammatory Biologics by Type (2015-2020)
Figure 81. Sales Market Share of Anti-inflammatory Biologics by Type in 2019
Figure 82. Revenue Share of Anti-inflammatory Biologics by Type (2015-2020)
Figure 83. Revenue Market Share of Anti-inflammatory Biologics by Type in 2019
Figure 84. Global Anti-inflammatory Biologics Sales Growth by Type (2015-2020) (K MT)
Figure 85. Global Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Figure 86. Global Anti-inflammatory Biologics Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Anti-inflammatory Biologics by Application (2015-2020)
Figure 88. Global Revenue Share of Anti-inflammatory Biologics by Application in 2020
Figure 89. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. AstraZeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Sun Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Anti-inflammatory Biologics
Figure 101. Manufacturing Process Analysis of Anti-inflammatory Biologics
Figure 102. Anti-inflammatory Biologics Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Anti-inflammatory Biologics Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 107. North America Anti-inflammatory Biologics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Anti-inflammatory Biologics Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Anti-inflammatory Biologics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Anti-inflammatory Biologics Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Anti-inflammatory Biologics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Anti-inflammatory Biologics Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Anti-inflammatory Biologics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Anti-inflammatory Biologics Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Anti-inflammatory Biologics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
